[1]毛汇炎,熊琨,唐乐微,等.原发性闭角型青光眼初始治疗方式的选择[J].眼科新进展,2024,44(5):405-409.[doi:10.13389/j.cnki.rao.2024.0079]
 MAO Huiyan,XIONG Kun,TANG Lewei,et al.Selection of initial treatment methods for primary angle closure glaucoma[J].Recent Advances in Ophthalmology,2024,44(5):405-409.[doi:10.13389/j.cnki.rao.2024.0079]
点击复制

原发性闭角型青光眼初始治疗方式的选择/HTML
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
44卷
期数:
2024年5期
页码:
405-409
栏目:
文献综述
出版日期:
2024-04-30

文章信息/Info

Title:
Selection of initial treatment methods for primary angle closure glaucoma
作者:
毛汇炎熊琨唐乐微梁远波
325027 浙江省温州市,温州医科大学附属眼视光医院(毛汇炎,熊琨,唐乐微,梁远波);325027 浙江省温州市,温州医科大学青光眼研究所 (毛汇炎,熊琨,唐乐微,梁远波)
Author(s):
MAO Huiyan12XIONG Kun12TANG Lewei12LIANG Yuanbo12
1.The Eye Hospital of Wenzhou Medical University,Wenzhou 325027,Zhejiang Province,China
2.Glaucoma Research Institute of Wenzhou Medical University,Wenzhou 325027,Zhejiang Province,China
关键词:
青光眼治疗手术
Keywords:
glaucoma treatment operation
分类号:
R775.2
DOI:
10.13389/j.cnki.rao.2024.0079
文献标志码:
A
摘要:
原发性闭角型青光眼(PACG)的治疗方式,尤其是初始治疗方式的选择对患者的预后至关重要。然而,目前多个PACG治疗指南策略各有不同。在治疗PACG时,应采用何种治疗方式作为首选治疗策略,迄今仍没有相关高级别的临床研究证据可供参考。本文对国内外针对PACG的治疗方式及其效果、影响因素、并发症等研究进行回顾与讨论,以期为PACG初始治疗方式选择提供参考。
Abstract:
The treatment of primary angle closure glaucoma (PACG), especially in the initial phase, is crucial to the prognostic effect. Currently, we have multiple PACG treatment options but lack high-level clinical research evidence as a reference for determining the optimal treatment strategy for PACG. This article reviews and discusses both domestic and international PACG treatment methods with their efficacy, influencing factors, and complications, providing a reference for the selection of initial treatment methods for PACG.

参考文献/References:

[1] SONG P,WANG J,BUCAN K,THEODORATOU E,RUDAN I,CHAN K Y.National and subnational prevalence and burden of glaucoma in China:a systematic analysis[J].J Glob Health,2017,7(2):020705.
[2] LIANG Y,FRIEDMAN D S,ZHOU Q,YANG X H,SUN L P,GUO L,et al.Prevalence and characteristics of primary angle-closure diseases in a rural adult Chinese population:the Handan Eye Study[J].Invest Ophthalmol Vis Sci,2011,52(12):8672-8679.
[3] European glaucoma society terminology and guidelines for glaucoma,5th edition[J].Br J Ophthalmol,2021,105(Suppl 1):1-169.
[4] GEDDE S J,CHEN P P,MUIR K W,VINOD K,LIND J T,WRIGHT M M,et al.Primary angle-closure disease preferred practice pattern?[J].Ophthalmology,2021,128(1):P30-P70.
[5] PRUM B E Jr,HERNDON L W Jr,MOROI S E,MANSBERGER S L,STEIN J D,LIM M C,et al.Primary angle closure preferred practice pattern(?) guidelines[J].Ophthalmology,2016,123(1):P1-P40.
[6] 中华医学会眼科学分会青光眼学组,中国医师协会眼科医师分会青光眼学组.中国青光眼指南(2020年)[J].中华眼科杂志,2020,56(8):573-586.
Glaucoma Group of Ophthalmology Branch of Chinese Medical Association,Glaucoma Group of Chinese Ophthalmologist Association.China glaucoma guide (2020)[J].Chin J Ophthalmol,2020,56(8):573-586.
[7] HAN S,SUNG K R,LEE K S,HONG J W.Outcomes of laser peripheral iridotomy in angle closure subgroups according to anterior segment optical coherence tomography parameters[J].Invest Ophthalmol Vis Sci,2014,55(10):6795-6801.
[8] ZEBARDAST N,KAVITHA S,KRISHNAMURTHY P,FRIEDMAN D S,NONGPIUR M E,AUNG T,et al.Changes in anterior segment morphology and predictors of angle widening after laser iridotomy in South Indian eyes[J].Ophthalmology,2016,123(12):2519-2526.
[9] RAO A,RAO H L,KUMAR A U,BABU J G,MADHULATA U,ARTHI J,et al.Outcomes of laser peripheral iridotomy in angle closure disease[J].Semin Ophthalmol,2013,28(1):4-8.
[10] PENG P H,NGUYEN H,LIN H S,NGUYEN N,LIN S.Long-term outcomes of laser iridotomy in Vietnamese patients with primary angle closure[J].Br J Ophthalmol,2011,95(9):1207-1211.
[11] BANSAL S,BALAKRISHNAN S A,BLACHLEY T,WEIZER J S,LEE P P,STEIN J D.Subsequent receipt of interventions for glaucoma among a nationwide sample of patients who underwent laser peripheral iridotomy[J].Am J Ophthalmol,2015,160(2):275-282.e4.
[12] LIM L S,HO C L,ANG L P K,AUNG T,TAN D T H.Inferior corneal decompensation following laser peripheral iridotomy in the superior iris[J].Am J Ophthalmol,2006,142(1):166-168.
[13] JIANG Y,CHANG D S,FOSTER P J,HE M,HUANG S,AUNG T,et al.Immediate changes in intraocular pressure after laser peripheral iridotomy in primary angle-closure suspects[J].Ophthalmology,2012,119(2):283-288.
[14] VIJAYA L,ASOKAN R,PANDAY M,GEORGE R.Is prophylactic laser peripheral iridotomy for primary angle closure suspects a risk factor for cataract progression? The Chennai Eye Disease Incidence Study[J].Br J Ophthalmol,2017,101(5):665-670.
[15] SRINIVASAN K,ZEBARDAST N,KRISHNAMURTHY P,ABDUL KADER M,RAMAN G V,RAJENDRABABU S,et al.Comparison of new visual disturbances after superior versus nasal/temporal laser peripheral iridotomy:a prospective randomized trial[J].Ophthalmology,2018,125(3):345-351.
[16] MOGHIMI S,CHEN R,JOHARI M,BIJANI F,MOHAMMADI M,KHODABANDEH A,et al.Changes in anterior segment morphology after laser peripheral iridotomy in acute primary angle closure[J].Am J Ophthalmol,2016,166:133-140.
[17] LIM L S,AUNG T,HUSAIN R,WU Y J,GAZZARD G,SEAH S K L.Acute primary angle closure:configuration of the drainage angle in the first year after laser peripheral iridotomy [J].Ophthalmology,2004,111(8):1470-1474.
[18] LAM D S,LEUNG D Y,THAM C C,LI F C,KWONG Y Y,CHIU T Y,et al.Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure[J].Ophthalmology,2008,115(7):1134-1140.
[19] 李思珍,梁远波,王宁利,孙霞,范肃洁,孙兰萍,等.周边虹膜前粘连范围对激光周边虹膜成形术治疗原发性闭角型青光眼急性发作期效果的影响[J].眼科,2019,28(1):23-28.
LI S Z,LIANG Y B,WANG N L,SUN X,FAN S J,SUN L P,et al.The effect of peripheral anterior synechia extent on intraocular pressure control of laser peripheral iridoplasty in acute primary angle-closure glaucoma[J].Ophthalmol China,2019,28(1):23-28.
[20] LAI J S,THAM C C,CHUA J K,POON A S,CHAN J C,LAM S W,et al.To compare argon laser peripheral iridoplasty (ALPI) against systemic medications in treatment of acute primary angle-closure:mid-term results[J].Eye (Lond),2006,20(3):309-314.
[21] 宋旭东,王宁利,唐广贤,李筱荣,张舒心,吕建华,等.超声乳化手术治疗原发性闭角型青光眼合并白内障的多中心试验[J].医学研究杂志,2010,39(3):17-22.
SONG X D,WANG N L,TANG G X,LI X R,ZHANG S X,L J H,et al.Multicentre trial of phacoemulsification on patients with primary angle-closure glaucoma and co-existing cataract[J].J Med Res,2010,39(3):17-22.
[22] WHITE A J,ORROS J M A,HEALEY P R.Outcomes of combined lens extraction and goniosynechialysis in angle closure[J].Clin Exp Ophthalmol,2013,41(8):746-752.
[23] ONG A Y,NG S M,VEDULA S S,FRIEDMAN D S.Lens extraction for chronic angle-closure glaucoma[J].Cochrane Database Syst Rev,2021,3(3):CD005555.
[24] MELESE E,PETERSON J R,FELDMAN R M,BAKER L A,BELL N P,CHUANG A Z,et al.Comparing laser peripheral iridotomy to cataract extraction in narrow angle eyes using anterior segment optical coherence tomography[J].PLoS ONE,2016,11(9):e0162283.
[25] THAM C C Y,LEUNG D Y L,KWONG Y Y Y,LI F C H,LAI J S M,LAM D S C.Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG)[J].J Glaucoma,2010,19(2):119-123.
[26] CHEN P P,LIN S C,JUNK A K,RADHAKRISHNAN S,SINGH K,CHEN T C.The effect of phacoemulsification on intraocular pressure in glaucoma patients:a report by the American academy of ophthalmology[J].Ophthalmology,2015,122(7):1294-1307.
[27] CHAN P P,TANG F Y,LEUNG D Y,LAM T C,BAIG N,THAM C C.Ten-year clinical outcomes of acute primary angle closure randomized to receive early phacoemulsification versus laser peripheral iridotomy[J].J Glaucoma,2021,30(4):332-339.
[28] TURALBA A,PAYAL A R,GONZALEZ-GONZALEZ L A,CAKINER-EGILMEZ T,CHOMSKY A S,VOLLMAN D E,et al.Cataract surgery outcomes in glaucomatous eyes:results from the veterans affairs ophthalmic surgery outcomes data project[J].Am J Ophthalmol,2015,160(4):693-701.e1.
[29] BAIG N,KAM K W,THAM C C Y.Managing primary angle closure glaucoma-the role of lens extraction in this era[J].Open Ophthalmol J,2016,10(1):86-93.
[30] PATEL H Y,DANESH-MEYER H V.Incidence and management of cataract after glaucoma surgery[J].Curr Opin Ophthalmol,2013,24(1):15-20.
[31] AZUARA-BLANCO A,BURR J,RAMSAY C,COOPER D,FOSTER P J,FRIEDMAN D S,et al.Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE):a randomised controlled trial[J].Lancet,2016,388(10052):1389-1397.
[32] NAPIER M L,AZUARA-BLANCO A.Changing patterns in treatment of angle closure glaucoma[J].Curr Opin Ophthalmol,2018,29(2):130-134.
[33] 马科,潘英姿.透明晶状体摘除术治疗原发性闭角型青光眼现阶段不适合在我国推广[J].中华眼科杂志,2018,54(3):169-170.
MA K,PAN Y Z.Clear lens extraction for primary angle-closure glaucoma is not suitable for popularization in China at this stage[J].Chin J Ophthalmol,2018,54(3):169-170.
[34] MOLTENO A C B,BOSMA N J,KITTELSON J M.Otago glaucoma surgery outcome study:long-term results of trabeculectomy--1976 to 1995 [J].Ophthalmology,1999,106(9):1742-1750.
[35] GUO X,LI B,FRIEDMAN D S,BOLAND M V.Surgical outcomes and quality assessment of trabeculectomy:leveraging electronic health records for clinical data visualization[J].J Glaucoma,2019,28(12):1023-1028.
[36] OLAYANJU J A,HASSAN M B,HODGE D O,KHANNA C L.Trabeculectomy-related complications in Olmsted County,Minnesota,1985 through 2010[J].JAMA Ophthalmol,2015,133(5):574-580.
[37] KRIX-JACHYM K,?ARNOWSKI T,R?KAS M.Risk factors of malignant glaucoma occurrence after glaucoma surgery[J].J Ophthalmol,2017,2017:9616738.
[38] GEDDE S J,FEUER W J,LIM K S,BARTON K,GOYAL S,AHMED I I,et al.Postoperative complications in the primary tube versus trabeculectomy study during 5 years of follow-up[J].Ophthalmology,2022,129(12):1357-1367.
[39] HIROOKA K,NITTA E,UKEGAWA K,SATO S,KIUCHI Y.Effect of trabeculectomy on corneal endothelial cell loss[J].Br J Ophthalmol,2020,104(3):376-380.
[40] CHEN Y Y,FAN S J,LIANG Y B,RONG S S,MENG H L,WANG X,et al.Laser peripheral iridotomy versus trabeculectomy as an initial treatment for primary angle-closure glaucoma[J].J Ophthalmol,2017,2017:2761301.
[41] 蔡世佳,王丽波,黄菁,陈舒怿.急性闭角型青光眼持续高眼压状态下手术方式的选择[J].国际眼科杂志,2010,10(5):867-870.
CAI S J,WANG L B,HUANG J,CHEN S Y.Reasonable emergency surgical method of the sustained high intraocular pressure of acute angle-closure glaucoma[J].Int J Ophthalmol,2010,10(5):867-870.
[42] ANSARI E.An update on implants for minimally invasive glaucoma surgery (MIGS)[J].Ophthalmol Ther,2017,6(2):233-241.
[43] HAMANAKA T,KASAHARA K,TAKEMURA T.Histopathology of the trabecular meshwork and Schlemm’s canal in primary angle-closure glaucoma[J].Invest Ophthalmol Vis Sci,2011,52(12):8849-8861.
[44] CHEN D Z,SNG C C A,SANGTAM T,THOMAS A,SHEN L,HUANG P K,et al.Phacoemulsification vs phacoemulsification with micro-bypass stent implantation in primary angle closure and primary angle closure glaucoma:a randomized single-masked clinical study[J].Clin Exp Ophthalmol,2020,48(4):450-461.
[45] CHIRA-ADISAI T,MORI K,KOBAYASHI A,UENO M,IKEDA Y,SOTOZONO C,et al.Outcomes of combined gonioscopy-assisted transluminal trabeculotomy and goniosynechialysis in primary angle closure:a retrospective case series[J].Int Ophthalmol,2021,41(4):1223-1231.
[46] DORAIRAJ S,TAM M D,BALASUBRAMANI G K.Twelve-month outcomes of excisional goniotomy using the Kahook Dual Blade? in eyes with angle-closure glaucoma[J].Clin Ophthalmol,2019,13:1779-1785.
[47] TANITO M,SUGIHARA K,TSUTSUI A,HARA K,MANABE K,MATSUOKA Y.Midterm results of microhook ab interno trabeculotomy in initial 560 eyes with glaucoma[J].J Clin Med,2021,10(4):814.
[48] ASANAD S,KALARN S,KALEEM M A.Postoperative complications of Ab-Interno XEN implantation in primary angle closure glaucoma[J].Am J Clin Exp Immunol,2021,10(1):44-47.
[49] CAMPBELL D G,VELA A.Modern goniosynechialysis for the treatment of synechial angle-closure glaucoma[J].Ophthalmology,1984,91(9):1052-1060.
[50] HARASYMOWYCZ P J,PAPAMATHEAKIS D G,AHMED I,ASSALIAN A,LESK M,AL-ZAFIRI Y,et al.Phacoemulsification and goniosynechialysis in the management of unresponsive primary angle closure[J].J Glaucoma,2005,14(3):186-189.
[51] LEE Y H,YUN Y M,KIM S H,LEE E K,LEE J E,KIM C S.Factors that influence intraocular pressure after cataract surgery in primary glaucoma[J].Can J Ophthalmol,2009,44(6):705-710.
[52] 唐艺华,李瑶瑶,解彦茜,张绍丹,许淑霞,乐融融,等.超声乳化白内障吸除联合房角镜指导下房角分离术中房角开放效果分析[J].中华眼科杂志,2022,58(9):701-705.
TANG Y H,LI Y Y,XIE Y Q,ZHANG S D,XU S X,LE R R,et al.Phacoemulsification combined with goniosynechialysis under a gonioscope in the treatment of angle-closure glaucoma:the effect of reopening the synechial anterior chamber angle[J].Chin J Ophthalmol,2022,58(9):701-705.
[53] WEI L,FU L,NIE L,LIAN H,QIAN Z,LIANG Y,et al.Efficacy of combined phacoemulsification and goniosynechialysis in primary angle closure disease with different degrees of peripheral anterior synechiae[J].J Glaucoma,2022,31(7):540-546.
[54] RODRIGUES I A,ALAGHBAND P,BELTRAN AGULLO L,GALVIS E,JONES S,HUSAIN R,et al.Aqueous outflow facility after phacoemulsification with or without goniosynechialysis in primary angle closure:a randomised controlled study[J].Br J Ophthalmol,2017,101(7):879-885.
[55] TUN T A,BASKARAN M,PERERA S A,HTOON H M,AUNG T,HUSAIN R.Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma[J].Br J Ophthalmol,2015,99(7):927-931.
[56] LEE C K,RHO S S,SUNG G J,KIM N R,YANG J Y,LEE N E,et al.Effect of goniosynechialysis during phacoemulsification on IOP in patients with medically well-controlled chronic angle-closure glaucoma[J].J Glaucoma,2015,24(6):405-409.
[57] NIE L,PAN W,FANG A,LI Z,QIAN Z,FU L,et al.Combined phacoemulsification and goniosynechialysis under an endoscope for chronic primary angle-closure glaucoma[J].J Ophthalmol,2018,2018:8160184.
[58] TIAN T,LI M,PAN Y,CAI Y,FANG Y.The effect of phacoemulsification plus goniosynechialysis in acute and chronic angle closure patients with extensive goniosynechiae[J].BMC Ophthalmol,2019,19(1):65.
[59] THAM C C,KWONG Y Y,LEUNG D Y,LAM S W,LI F C,CHIU T Y,et al.Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract [J].Ophthalmology,2008,115(12):2167-2173.e2162.
[60] THAM C C,KWONG Y Y,LEUNG D Y,LAM S W,LI F C,CHIU T Y,et al.Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts[J].Ophthalmology,2009,116(4):725-731, 731.e1-731.e3.

相似文献/References:

[1]李翔 谢钊 郭红建 谢学军 路雪婧 王毅 王超.补肾活血中药对大鼠慢性高眼压模型外侧膝状体病理改变的影响[J].眼科新进展,2012,32(1):000.
[2]范虹 刘五存 蔡鸿英 赵堪兴.改良二极管激光睫状体光凝术治疗中晚期青光眼[J].眼科新进展,2012,32(4):000.
[3]王建萍 赵燕麟 马勇 朱涛 程燕 车选义 赵桂娥 王柯.噻吗洛尔和布林佐胺联合曲伏前列素治疗原发性开角型青光眼与高眼压患者的临床研究[J].眼科新进展,2012,32(5):000.
[4]周朋义 彭广华.视网膜色素变性治疗的研究进展[J].眼科新进展,2012,32(5):000.
[5]杨红 阴正勤.眼球震颤的诊断与治疗研究进展[J].眼科新进展,2012,32(5):000.
[6]彭坤 靳隽 杨玉新 许银霞 王保君 闫义涛 杨华.长期联合应用噻吗洛尔对结膜组织炎性标记物ICAM-1和HLA-DR表达的影响[J].眼科新进展,2012,32(6):000.
[7]马恩普 赵小钊 董良 刘苏冰 曾照年.Healaflow在青光眼小梁切除术中的应用[J].眼科新进展,2012,32(6):000.
[8]王勇 叶应嘉 鲍先议 周龑丽 许荣 彭婷婷 曾志富.同轴微小切口超声乳化吸出术在青光眼滤过术后白内障摘出术中的应用[J].眼科新进展,2012,32(7):000.
[9]李翔 马世勇 李娟 王毅.补肾活血中药对大鼠慢性高眼压模型视神经病理改变的影响[J].眼科新进展,2013,33(2):000.
[10]邵毅 周琼 易昀敏 余瑶 裴重刚 吴晓蓉 梅峰 占敏艳.鬼针草叶治疗非增生型糖尿病视网膜病变的临床研究[J].眼科新进展,2013,33(6):000.
[11]邵毅.青光眼诊断与治疗规范——2017年英国专家共识解读[J].眼科新进展,2018,38(11):1001.[doi:10.13389/j.cnki.rao.2018.0236]
 SHAO Yi.Standardized glaucoma treatment:Interpretation of 2017 diagnostic and management guidelines of glaucoma by the British National Institute for Health and Care Excellence(NICE)[J].Recent Advances in Ophthalmology,2018,38(5):1001.[doi:10.13389/j.cnki.rao.2018.0236]

备注/Memo

备注/Memo:
国家重点研发计划(编号:2020YFC2008200); 温州医科大学附属眼视光医院院内课题(编号:KYQD20220304)
更新日期/Last Update: 2024-05-05